Empagliflozin and Metformin Extended-Release Tablets and Semaglutide Subcutaneous
Determining the interaction of Empagliflozin and Metformin Extended-Release Tablets and Semaglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / metformin
Brand name: Synjardy, Synjardy XR
Synonyms: Empagliflozin and metformin, Empagliflozin and Metformin
Generic Name: semaglutide
Brand name: Ozempic, Rybelsus
Synonyms: Semaglutide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and Metformin Extended-Release Tablets-Semaglutide Tablets
- Empagliflozin and Metformin Extended-Release Tablets-Semprex-D
- Empagliflozin and Metformin Extended-Release Tablets-Semprex-D Oral
- Empagliflozin and Metformin Extended-Release Tablets-Senatec Topical application
- Empagliflozin and Metformin Extended-Release Tablets-Senexon
- Empagliflozin and Metformin Extended-Release Tablets-Senexon-S
- Semaglutide Subcutaneous-Empagliflozin and Metformin Tablets
- Semaglutide Subcutaneous-Empliciti
- Semaglutide Subcutaneous-Emsam
- Semaglutide Subcutaneous-Emsam Transdermal
- Semaglutide Subcutaneous-Emtricitabine
- Semaglutide Subcutaneous-Emtricitabine and tenofovir